期刊文献+

COX-2、Survivin在乳腺良、恶性疾病中的表达及其意义

Expression and clinical significance of COX-2,Survivin in breast benign lesion and breast carcinoma
在线阅读 下载PDF
导出
摘要 目的:探讨环氧化酶-2(COX-2)和生存素(Survivin)在乳腺良性病变、乳腺导管原位癌及乳腺浸润性导管癌中的表达及其临床意义。方法:应用免疫组化染色法检测乳腺良性病变、乳腺导管原位癌、乳腺浸润性导管癌组织中COX-2和Survivin的表达情况。结果:COX-2在乳腺浸润性导管癌中的阳性表达率为81.67%,明显高于乳腺良性病变(50.00%)和乳腺导管原位癌(76.67%),差异有统计学意义(P<0.05)。Survivin在乳腺浸润性导管癌中阳性表达率为70.00%,明显高于乳腺良性病变(41.67%)和乳腺导管原位癌(60.00%),差异有统计学意义(P<0.05)。COX-2阳性表达与乳腺癌腋窝淋巴结转移、临床分期、雌激素受体(ER)阳性表达有关(P<0.05),而与患者发病年龄、肿瘤大小、孕激素受体(PR)情况、患者是否绝经无关(P>0.05)。Survivin阳性表达与乳腺癌腋窝淋巴结转移及临床分期有关(P<0.05),而与患者年龄、肿瘤大小、ER、PR、患者是否绝经无关(P>0.05)。在乳腺浸润性导管癌中COX-2阳性表达与Survivin阳性表达呈正相关(r=0.33,P<0.05)。结论:COX-2与Survivin在乳腺癌的发生、发展中起重要作用。COX-2与Survivin阳性表达密切相关,在乳腺癌的发生、发展中起协同作用。 Objective: To investigate the relationship between the expression of cyelooxygenase-2 (COX-2) and survivin in breast benign lesion, ductal carcinoma in situ and invasive breast carcinoma and their clinical significances. Methods: Sixty cases of breast benign lesion, 60 cases of ductal carcinoma in situ and 60 cases of in invasive breast carcinoma were detected by of the immunohistochemical staining. Results: The positive rate of COX-2 were 50.00% (30/60) in breast benign lesion, 76.67%(46/60) in breast ductal car- cinoma in situ and 81.67%(49/60) in breast invasive ductal carcinoma, the difference showed statistically significance (P 〈0.05). In breast benign lesion the positive rate of survivin was 41. 67% (25/60), in breast ductal carcinoma in situ it was 60.00% (36/60), in breast invasive ductal carcinoma the positive rate of survivin was 70.00% (42/60), which were significantly different (P〈0.05). COX-2 expression was not associated with patient's age, tumor size, PR state, menopause or not (P〉0.05), but it was correlated with patient's lymph node metastasis, clinical stages, estrogen receptor positive (P 〈0.05). Survivin expression was not associated with patient's age, tumor size, ER state, PR state, menopause or not (P〉0.05), but it was correlated with patient's lymphnode metastasis, clinical stages (P 〈0.05). COX-2 expression was positive relation to survivin expression (r = 0.33 ,P 〈0.05). Conclusion: COX-2 and survivin might play an important role in the carcinogenesis and progression in breast carcinoma. A positive correla- tion between expression of COX-2 and survivin were observed in breast carcinoma,COX-2 has coordinated action with survivin in the carcinogenesis and progression in breast carcinoma.
出处 《新疆医科大学学报》 CAS 2008年第11期1528-1530,1533,共4页 Journal of Xinjiang Medical University
关键词 环氧化酶-2 生存素 乳腺癌 免疫组化 cyclooxygenase-2 survivin breast carcinoma immuno-histochemistry
作者简介 艾秀清(1975-),女,住院医师,硕士研究生,研究方向:乳腺肿瘤放射治疗。
  • 相关文献

参考文献10

  • 1郭贵龙,姚榛祥,吴坚.环氧化酶-2基因在人乳腺癌中的表达及临床意义[J].中华医学杂志,2003,83(19):1661-1664. 被引量:38
  • 2刘江伟,李开宗,窦科峰,马福成,王映梅.胰腺癌组织survivin和COX-2表达的相关性[J].第四军医大学学报,2004,25(7):635-636. 被引量:33
  • 3Molin MA, Sitja-Amau M, Lemoina MG, et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal antiinfalmmatoy drugs[J]. Cancer Res, 1999,59 (17): 4356-4362.
  • 4Howe LR, Subbaramaiah K, Brown AMC, et ai. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer [J]. Endocrine Related Cancer, 2001,8(2):97-114.
  • 5Half E,Tang XY,Gwyn K, et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal earinoma in Situ [J]. Cancer Res,2002,62(6) :1676-1681.
  • 6Costa C, Snares R, Reis-Fihlho JS, et al. Cyclooxygenase-2 expression is associated with angigogenesis and lymph node metastasis in human breast cancer[J]. J Clin Pathol, 2002, 55:429-434.
  • 7Tomozawa S, Tsuno NH, Sunaml E, et al. Cyclooxygenase-2 overexpression correlates mith tumor recurrence especially hematogenous metastasis of coloretal[J]. Br J Cancer,2000,61 (3) :324-328.
  • 8Kajiwara Y, Yamasaki F, Hama S, et al. Expression of survivin in astrocytic tumors: correlation with malignant grade prognosis[J]. Cancer, 2003,97(4) : 1077-1083.
  • 9张淑群,强水云,杨文彬,姜建涛,纪宗正.Survivin蛋白在乳腺癌发生、发展不同阶段的表达及意义[J].癌症,2004,23(6):697-700. 被引量:28
  • 10Tanaka K, Iwamoto S, Gon G, et al. Expression of Survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res, 2000,6 : 127-132.

二级参考文献21

  • 1[1]Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7[J]. Biochemistry, 2001;40(4):1117-1123.
  • 2[2]Moran EM. Epidemiological and clinical aspects of nonsteroidalanti-inflammatory drugs and cancer risks[J]. J Environ Pathol Toxicol Oncol, 2002; 21(2):193-220.
  • 3[3]Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy [J] . Trends Mol Med, 2001;7(12):542-547.
  • 4Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases [J] . Nature, 1997, 388(6639): 300 - 304.
  • 5Rohayem J, Diestelkoetter P, Weigle B, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein in cancer patients [J]. Cancer Res, 2000, 60(7): 1815 - 1817.
  • 6Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and caspase-7 [J].Biochemistry, 2001, 40 (4): 1117 - 1123.
  • 7Koch CA, Vortmeyer AO, Diallo R, et al. Survivin: a novel neuroendocrine marker for pheochromocytoma [J]. Eur J Endocrinol, 2002, 146 (3): 381 - 388.
  • 8Ikeguchi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patient with hapatocellular carcinoma [J] . Diagn Mol Pathol, 2002, 11 (1):33 - 40.
  • 9Chakravarti A, Noll E, Black PM, et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas [J]. J Clin Oncol, 2002, 20(4): 1063 - 1068.
  • 10Tanaka K, Iwamoto S, Gon G,et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res,2000, 6:127 - 134.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部